Annual EBITDA:
$3.93M+$30.70M(+114.68%)Summary
- As of today, DVAX annual EBITDA is $3.93 million, with the most recent change of +$30.70 million (+114.68%) on December 31, 2024.
- During the last 3 years, DVAX annual EBITDA has fallen by -$136.07 million (-97.19%).
- DVAX annual EBITDA is now -98.65% below its all-time high of $291.41 million, reached on December 31, 2022.
Performance
DVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$23.36M+$6.90M(+41.88%)Summary
- As of today, DVAX quarterly EBITDA is $23.36 million, with the most recent change of +$6.90 million (+41.88%) on September 30, 2025.
- Over the past year, DVAX quarterly EBITDA has increased by +$11.23 million (+92.53%).
- DVAX quarterly EBITDA is now -81.98% below its all-time high of $129.67 million, reached on June 30, 2022.
Performance
DVAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$18.68M+$11.23M(+150.75%)Summary
- As of today, DVAX TTM EBITDA is $18.68 million, with the most recent change of +$11.23 million (+150.75%) on September 30, 2025.
- Over the past year, DVAX TTM EBITDA has increased by +$18.18 million (+3665.73%).
- DVAX TTM EBITDA is now -93.95% below its all-time high of $308.63 million, reached on September 30, 2022.
Performance
DVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DVAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +114.7% | +92.5% | +3665.7% |
| 3Y3 Years | -97.2% | -63.1% | -94.0% |
| 5Y5 Years | +104.0% | +228.3% | +124.6% |
DVAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -98.7% | +114.7% | -64.2% | +183.8% | -94.0% | +169.8% |
| 5Y | 5-Year | -98.7% | +104.0% | -82.0% | +183.8% | -94.0% | +124.6% |
| All-Time | All-Time | -98.7% | +102.9% | -82.0% | +168.0% | -94.0% | +113.7% |
DVAX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $23.36M(+41.9%) | $18.68M(+150.7%) |
| Jun 2025 | - | $16.47M(+176.3%) | $7.45M(+860.1%) |
| Mar 2025 | - | -$21.59M(-5018.9%) | -$980.00K(-116.4%) |
| Dec 2024 | $3.93M(+114.7%) | $439.00K(-96.4%) | $5.98M(+1106.0%) |
| Sep 2024 | - | $12.14M(+51.0%) | $496.00K(+110.4%) |
| Jun 2024 | - | $8.04M(+154.9%) | -$4.76M(+64.8%) |
| Mar 2024 | - | -$14.63M(-189.9%) | -$13.51M(+49.5%) |
| Dec 2023 | -$26.77M(-109.2%) | -$5.05M(-173.4%) | -$26.77M(-161.6%) |
| Sep 2023 | - | $6.88M(+1062.2%) | $43.49M(-56.5%) |
| Jun 2023 | - | -$715.00K(+97.4%) | $99.94M(-56.6%) |
| Mar 2023 | - | -$27.89M(-142.8%) | $230.32M(-21.0%) |
| Dec 2022 | $291.41M(+108.1%) | $65.22M(+3.0%) | $291.41M(-5.6%) |
| Sep 2022 | - | $63.33M(-51.2%) | $308.63M(+18.8%) |
| Jun 2022 | - | $129.67M(+290.6%) | $259.74M(+83.5%) |
| Mar 2022 | - | $33.20M(-59.7%) | $141.52M(+1.7%) |
| Dec 2021 | $140.00M(+312.5%) | $82.44M(+471.2%) | $139.09M(+199.0%) |
| Sep 2021 | - | $14.43M(+26.1%) | $46.52M(+235.1%) |
| Jun 2021 | - | $11.45M(-62.8%) | $13.88M(+175.3%) |
| Mar 2021 | - | $30.77M(+403.7%) | -$18.44M(+71.1%) |
| Dec 2020 | -$65.89M(+32.5%) | -$10.13M(+44.3%) | -$63.85M(+15.8%) |
| Sep 2020 | - | -$18.21M(+12.8%) | -$75.84M(+0.4%) |
| Jun 2020 | - | -$20.88M(-42.7%) | -$76.14M(+5.1%) |
| Mar 2020 | - | -$14.63M(+33.9%) | -$80.24M(+17.8%) |
| Dec 2019 | -$97.66M(+28.2%) | -$22.12M(-19.5%) | -$97.66M(+10.9%) |
| Sep 2019 | - | -$18.51M(+25.9%) | -$109.61M(+12.2%) |
| Jun 2019 | - | -$24.98M(+22.1%) | -$124.89M(+7.0%) |
| Mar 2019 | - | -$32.05M(+5.9%) | -$134.25M(+1.3%) |
| Dec 2018 | -$136.04M(-58.2%) | -$34.07M(-0.8%) | -$136.07M(-7.0%) |
| Sep 2018 | - | -$33.79M(+1.6%) | -$127.14M(-11.3%) |
| Jun 2018 | - | -$34.35M(-1.4%) | -$114.25M(-15.0%) |
| Mar 2018 | - | -$33.86M(-34.7%) | -$99.33M(-14.7%) |
| Dec 2017 | -$86.01M(+18.9%) | -$25.14M(-20.4%) | -$86.64M(-9.1%) |
| Sep 2017 | - | -$20.89M(-7.5%) | -$79.41M(+13.8%) |
| Jun 2017 | - | -$19.44M(+8.2%) | -$92.17M(+8.7%) |
| Mar 2017 | - | -$21.17M(-18.2%) | -$101.00M(+4.7%) |
| Dec 2016 | -$105.99M(-3.9%) | -$17.91M(+46.8%) | -$105.99M(+7.5%) |
| Sep 2016 | - | -$33.65M(-19.0%) | -$114.62M(-5.3%) |
| Jun 2016 | - | -$28.27M(-8.1%) | -$108.84M(-5.7%) |
| Mar 2016 | - | -$26.16M(+1.4%) | -$103.01M(-0.5%) |
| Dec 2015 | -$101.99M(-16.7%) | -$26.54M(+4.8%) | -$102.45M(-5.3%) |
| Sep 2015 | - | -$27.88M(-24.2%) | -$97.28M(+1.9%) |
| Jun 2015 | - | -$22.44M(+12.3%) | -$99.14M(+2.0%) |
| Mar 2015 | - | -$25.60M(-19.8%) | -$101.22M(-13.4%) |
| Dec 2014 | -$87.42M(-34.2%) | -$21.37M(+28.2%) | -$89.25M(-10.8%) |
| Sep 2014 | - | -$29.74M(-21.3%) | -$80.53M(-25.2%) |
| Jun 2014 | - | -$24.51M(-79.9%) | -$64.30M(-16.5%) |
| Mar 2014 | - | -$13.63M(-7.7%) | -$55.21M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$65.16M(+1.8%) | -$12.65M(+6.4%) | -$60.94M(+10.4%) |
| Sep 2013 | - | -$13.51M(+12.4%) | -$67.98M(+4.6%) |
| Jun 2013 | - | -$15.42M(+20.3%) | -$71.27M(-1.1%) |
| Mar 2013 | - | -$19.36M(+1.7%) | -$70.49M(-15.2%) |
| Dec 2012 | -$66.39M(-44.4%) | -$19.69M(-17.3%) | -$61.19M(-33.2%) |
| Sep 2012 | - | -$16.79M(-14.6%) | -$45.94M(-5.2%) |
| Jun 2012 | - | -$14.65M(-45.7%) | -$43.66M(-12.8%) |
| Mar 2012 | - | -$10.05M(-126.5%) | -$38.71M(+15.8%) |
| Dec 2011 | -$45.98M(-1.7%) | -$4.44M(+69.4%) | -$45.98M(+19.2%) |
| Sep 2011 | - | -$14.52M(-49.7%) | -$56.91M(-16.6%) |
| Jun 2011 | - | -$9.70M(+44.0%) | -$48.80M(+10.9%) |
| Mar 2011 | - | -$17.32M(-12.7%) | -$54.76M(-19.7%) |
| Dec 2010 | -$45.19M(-268.1%) | -$15.37M(-139.9%) | -$45.74M(-10.7%) |
| Sep 2010 | - | -$6.41M(+59.1%) | -$41.32M(+8.0%) |
| Jun 2010 | - | -$15.65M(-88.5%) | -$44.90M(-75.1%) |
| Mar 2010 | - | -$8.31M(+24.1%) | -$25.64M(-108.9%) |
| Dec 2009 | -$12.28M(+42.3%) | -$10.95M(-9.6%) | -$12.28M(-1623.3%) |
| Sep 2009 | - | -$9.99M(-377.4%) | $806.00K(-86.0%) |
| Jun 2009 | - | $3.60M(-28.8%) | $5.74M(+242.5%) |
| Mar 2009 | - | $5.06M(+136.7%) | -$4.03M(+81.7%) |
| Dec 2008 | -$21.29M(+66.3%) | $2.14M(+142.2%) | -$22.02M(+41.9%) |
| Sep 2008 | - | -$5.06M(+17.9%) | -$37.93M(+26.2%) |
| Jun 2008 | - | -$6.16M(+52.4%) | -$51.41M(+22.6%) |
| Mar 2008 | - | -$12.94M(+6.0%) | -$66.45M(+3.7%) |
| Dec 2007 | -$63.16M(-5.8%) | -$13.77M(+25.8%) | -$69.00M(+10.3%) |
| Sep 2007 | - | -$18.54M(+12.5%) | -$76.89M(-3.6%) |
| Jun 2007 | - | -$21.20M(-36.9%) | -$74.19M(-11.4%) |
| Mar 2007 | - | -$15.49M(+28.5%) | -$66.60M(-11.2%) |
| Dec 2006 | -$59.67M(-174.6%) | -$21.66M(-36.7%) | -$59.89M(-26.0%) |
| Sep 2006 | - | -$15.85M(-16.4%) | -$47.52M(-18.2%) |
| Jun 2006 | - | -$13.61M(-55.2%) | -$40.19M(-13.6%) |
| Mar 2006 | - | -$8.77M(+5.5%) | -$35.39M(-62.9%) |
| Dec 2005 | -$21.73M(-33.1%) | -$9.29M(-9.0%) | -$21.73M(-22.7%) |
| Sep 2005 | - | -$8.52M(+3.3%) | -$17.71M(-32.4%) |
| Jun 2005 | - | -$8.81M(-280.3%) | -$13.38M(-76.7%) |
| Mar 2005 | - | $4.89M(+192.8%) | -$7.57M(+53.6%) |
| Dec 2004 | -$16.32M(+5.0%) | -$5.27M(-25.7%) | -$16.32M(-4.9%) |
| Sep 2004 | - | -$4.19M(-39.4%) | -$15.56M(-37.1%) |
| Jun 2004 | - | -$3.00M(+22.3%) | -$11.35M(-37.6%) |
| Mar 2004 | - | -$3.87M(+14.1%) | -$8.25M(-88.2%) |
| Dec 2003 | -$17.19M(+4.4%) | -$4.50M(>-9900.0%) | -$4.38M(-3781.5%) |
| Sep 2003 | - | $23.00K(-76.0%) | $119.00K(+24.0%) |
| Jun 2003 | - | $96.00K | $96.00K |
| Dec 2002 | -$17.98M(+5.6%) | - | - |
| Dec 2001 | -$19.06M(-103.8%) | - | - |
| Dec 2000 | -$9.35M(-38.1%) | - | - |
| Dec 1999 | -$6.77M | - | - |
FAQ
- What is Dynavax Technologies Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Dynavax Technologies Corporation?
- What is Dynavax Technologies Corporation annual EBITDA year-on-year change?
- What is Dynavax Technologies Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Dynavax Technologies Corporation?
- What is Dynavax Technologies Corporation quarterly EBITDA year-on-year change?
- What is Dynavax Technologies Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Dynavax Technologies Corporation?
- What is Dynavax Technologies Corporation TTM EBITDA year-on-year change?
What is Dynavax Technologies Corporation annual EBITDA?
The current annual EBITDA of DVAX is $3.93M
What is the all-time high annual EBITDA for Dynavax Technologies Corporation?
Dynavax Technologies Corporation all-time high annual EBITDA is $291.41M
What is Dynavax Technologies Corporation annual EBITDA year-on-year change?
Over the past year, DVAX annual EBITDA has changed by +$30.70M (+114.68%)
What is Dynavax Technologies Corporation quarterly EBITDA?
The current quarterly EBITDA of DVAX is $23.36M
What is the all-time high quarterly EBITDA for Dynavax Technologies Corporation?
Dynavax Technologies Corporation all-time high quarterly EBITDA is $129.67M
What is Dynavax Technologies Corporation quarterly EBITDA year-on-year change?
Over the past year, DVAX quarterly EBITDA has changed by +$11.23M (+92.53%)
What is Dynavax Technologies Corporation TTM EBITDA?
The current TTM EBITDA of DVAX is $18.68M
What is the all-time high TTM EBITDA for Dynavax Technologies Corporation?
Dynavax Technologies Corporation all-time high TTM EBITDA is $308.63M
What is Dynavax Technologies Corporation TTM EBITDA year-on-year change?
Over the past year, DVAX TTM EBITDA has changed by +$18.18M (+3665.73%)